American Journal of Epidemiology Vol. 148, No. 9: 887-892
Copyright © 1998 by The Johns Hopkins University School of Hygiene and Public Health
other |
Cognitive Impairment, Drug Use, and the Risk of Hip Fracture in Persons over 75 Years Old: A Community-based Prospective Study
From the Stockholm Gerontology Research Center and Department of Geriatric Medicine, Karolinska Institute Stockholm, Sweden.
Reprint requests to Dr. Zhenchao Guo, Stockholm Gerontology Research Center, Box 6401, S-113 82 Stockholm, Sweden.
The authors examined the effects of cognitive function, as assessed by the Mini-Mental State Examination, and drug use on the incidence of hip fracture in a community-based Swedish population of 1,608 subjects who were aged 
75 years on October 1,1987, and who had not had a hip fracture. During the 7,123.8 person-year follow-up, 134 first hip fractures were identified. The Cox proportional hazards model was used to estimate the relative risk of developing hip fracture, taking into account several potential confounders. Compared with those without cognitive impairment, subjects with mild impairment (Mini-Mental State Examination scores 18–23) had a relative risk of 2.04 (95% confidence interval (Cl) 1.29–3.24), and subjects with moderate-severe impairment (Mini-Mental State Examination score <18) had a relative risk of 2.09 (95% Cl 1.17–3.72). Subjects using opioid analgesics (97% took propoxyphene) had a relative risk of 2.01 (95% Cl 1.19–3.40). Taking potassium supplements (99% took potassium chloride) was related to a reduced risk of hip fracture (relative risk = 0.55, 95% Cl 0.31–0.98), while diuretics did not have an independent impact. In summary, the results show that cognitive impairment and use of propoxyphene are associated with increased risk of hip fracture. The observed protection of potassium chloride merits further attention. The limitation of the study was that the assessment of drug use was made only at baseline. Am J Epidemiol 1998; 148:887–92.
cognition; hip fractures; potassium; propoxyphene
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Nakamura, S. Takahashi, M. Oyama, M. Nashimoto, T. Saito, Y. Tsuchiya, Y. Yoshizawa, and M. Yamamoto Incidence and risk factors associated with hip fracture in institutionalised elderly people in Japan Age Ageing, July 1, 2009; 38(4): 478 - 482. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hartikainen, E. Lonnroos, and K. Louhivuori Medication as a Risk Factor for Falls: Critical Systematic Review J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1172 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hix Pain Management in Elderly Patients Journal of Pharmacy Practice, February 1, 2007; 20(1): 49 - 63. [Abstract] [PDF]
|
|
|
|
 |
|
 D. G. Hackam, A. Kopp, and D. A. Redelmeier Prognostic Implications of Warfarin Cessation After Major Trauma: A Population-Based Cohort Analysis Circulation, May 3, 2005; 111(17): 2250 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Kern, N. R. Powe, M. A. Levine, A. L. Fitzpatrick, T. B. Harris, J. Robbins, and L. P. Fried Association between Screening for Osteoporosis and the Incidence of Hip Fracture Ann Intern Med, February 1, 2005; 142(3): 173 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Wagner, F. Zhang, S. B. Soumerai, A. M. Walker, J. H. Gurwitz, R. J. Glynn, and D. Ross-Degnan Benzodiazepine Use and Hip Fractures in the Elderly: Who Is at Greatest Risk? Arch Intern Med, July 26, 2004; 164(14): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Daniell Opioid Osteoporosis Arch Intern Med, February 9, 2004; 164(3): 338 - 338. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Chutka, P. Y. Takahashi, and R. W. Hoel Inappropriate Medications for Elderly Patients Mayo Clin. Proc., January 1, 2004; 79(1): 122 - 139. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R. Waldstein, C. F. Tankard, K. J. Maier, J. R. Pelletier, J. Snow, A. W. Gardner, R. Macko, and L. I. Katzel Peripheral Arterial Disease and Cognitive Function Psychosom Med, September 1, 2003; 65(5): 757 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Ensrud, T. Blackwell, C. M. Mangione, P. J. Bowman, D. C. Bauer, A. Schwartz, J. T. Hanlon, M. C. Nevitt, and M. A. Whooley Central Nervous System Active Medications and Risk for Fractures in Older Women Arch Intern Med, April 28, 2003; 163(8): 949 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Raja, J. A. Haythornthwaite, M. Pappagallo, M. R. Clark, T. G. Travison, S. Sabeen, R. M. Royall, and M. B. Max Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial Neurology, October 8, 2002; 59(7): 1015 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Dennis, K. M. Lo, M. McDowall, and T. West Fractures After Stroke: Frequency, Types, and Associations Stroke, March 1, 2002; 33(3): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Guo, L. Fratiglioni, M. Viitanen, L. Lannfelt, H. Basun, J. Fastbom, and B. Winblad Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication? Am. J. Epidemiol., February 1, 2001; 153(3): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Chandler, S. I. Zimmerman, C. J. Girman, A. R. Martin, W. Hawkes, J. R. Hebel, P. D. Sloane, L. Holder, and J. Magaziner Low Bone Mineral Density and Risk of Fracture in White Female Nursing Home Residents JAMA, August 23, 2000; 284(8): 972 - 977. [Abstract] [Full Text] [PDF]
|
|